Differences in Wound Healing in Mice with Deficiency of IL-6 versus IL-6 Receptor
暂无分享,去创建一个
S. Kozma | C. Mercer | M. Zhou | Molly M. McFarland-Mancini | A. Drew | P. Giridhar | Holly M. Funk | Andrew M. Paluch
[1] W. Ferlin,et al. The IL-27 p28 Subunit Binds Cytokine-Like Factor 1 to Form a Cytokine Regulating NK and T Cell Activities Requiring IL-6R for Signaling1 , 2009, The Journal of Immunology.
[2] C. Riley,et al. Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial–mesenchymal transition in ovarian carcinomas , 2008, British Journal of Cancer.
[3] Philip M Murphy,et al. SOCS3 negatively regulates the gp130-STAT3 pathway in mouse skin wound healing. , 2008, The Journal of investigative dermatology.
[4] J. Scheller,et al. Transgenic blockade of interleukin 6 transsignaling abrogates inflammation. , 2008, Blood.
[5] C. Fielding,et al. Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils. , 2007, Blood.
[6] R. Gallucci,et al. Interleukin‐6 (IL‐6) modulates migration and matrix metalloproteinase function in dermal fibroblasts from IL‐6KO mice , 2007, The British journal of dermatology.
[7] J. Scheller,et al. Interleukin‐6 biology is coordinated by membrane‐bound and soluble receptors: role in inflammation and cancer , 2006, Journal of leukocyte biology.
[8] Serge Haan,et al. Multiple reasons for an inefficient STAT1 response upon IL-6-type cytokine stimulation. , 2005, Cellular signalling.
[9] Paul Martin,et al. Inflammatory cells during wound repair: the good, the bad and the ugly. , 2005, Trends in cell biology.
[10] J. Scheller,et al. IL-6 transsignaling: the in vivo consequences. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[11] A. Ullrich,et al. Mammary Gland Remodeling Depends on gp130 Signaling through Stat3 and MAPK* , 2004, Journal of Biological Chemistry.
[12] M. Schwaninger,et al. The role of interleukin-6 in stress-induced hyperthermia and emotional behaviour in mice , 2003, Behavioural Brain Research.
[13] Stefan Rose-John,et al. Interplay between IFN-γ and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation , 2003 .
[14] N. Mukaida,et al. Essential involvement of IL‐6 in the skin wound‐healing process as evidenced by delayed wound healing in IL‐6‐deficient mice , 2003, Journal of leukocyte biology.
[15] L. DiPietro,et al. Accelerated wound closure in neutrophil‐depleted mice , 2003, Journal of leukocyte biology.
[16] S. Rose-John,et al. Signaling of Human Ciliary Neurotrophic Factor (CNTF) Revisited , 2003, The Journal of Biological Chemistry.
[17] P. Igaz,et al. Soluble interleukin-6 receptor enhanced by oncostatin M induces major changes in gene expression profile of human hepatoma cells. , 2002, Immunology letters.
[18] H. Ahorn,et al. N-myc oncogene overexpression down-regulates IL-6; evidence that IL-6 inhibits angiogenesis and suppresses neuroblastoma tumor growth , 2002, Oncogene.
[19] T. Glant,et al. Shedding of the Interleukin-6 (IL-6) Receptor (gp80) Determines the Ability of IL-6 to Induce gp130 Phosphorylation in Human Osteoblasts* , 2002, The Journal of Biological Chemistry.
[20] J. D. Vos,et al. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells , 2002, Oncogene.
[21] R. Gilmont,et al. MAP kinase pathways involving hsp27 regulate fibroblast-mediated wound contraction. , 2002, The Journal of surgical research.
[22] C. Begley,et al. An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells , 2002, Oncogene.
[23] T. S. Wilkinson,et al. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. , 2001, Immunity.
[24] M. Luster,et al. Impaired cutaneous wound healing in interleukin‐6‐deficient and immunosuppressed mice , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] J. Heath,et al. Receptor recognition by gp130 cytokines , 2000, The EMBO journal.
[26] H. Baumann,et al. Dual Signaling Role of the Protein Tyrosine Phosphatase SHP-2 in Regulating Expression of Acute-Phase Plasma Proteins by Interleukin-6 Cytokine Receptors in Hepatic Cells , 1999, Molecular and Cellular Biology.
[27] W. Reith,et al. Conditional gene targeting in macrophages and granulocytes using LysMcre mice , 1999, Transgenic Research.
[28] H. Baumann,et al. The STAT3-independent Signaling Pathway by Glycoprotein 130 in Hepatic Cells* , 1999, The Journal of Biological Chemistry.
[29] M. Magnuson,et al. Dual Roles for Glucokinase in Glucose Homeostasis as Determined by Liver and Pancreatic β Cell-specific Gene Knock-outs Using Cre Recombinase* , 1999, The Journal of Biological Chemistry.
[30] Simon A. Jones,et al. Shedding of the soluble IL‐6 receptor is triggered by Ca2+ mobilization, while basal release is predominantly the product of differential mRNA splicing in THP‐1 cells , 1998, European journal of immunology.
[31] P. Angrand,et al. Improved properties of FLP recombinase evolved by cycling mutagenesis , 1998, Nature Biotechnology.
[32] L. Moldawer,et al. Interleukin 6, but not ciliary neurotrophic factor or leukaemia inhibitory factor, is responsible for the acute phase response to turpentine-induced myositis. , 1998, Cytokine.
[33] H. Kung,et al. Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells , 1998, Nature.
[34] A. Ben-nun,et al. Interleukin‐6 functions in autoimmune encephalomyelitis: a study in gene‐targeted mice , 1998, European journal of immunology.
[35] T. Bugge,et al. Ligneous conjunctivitis in plasminogen-deficient mice. , 1998, Blood.
[36] W. Schiemann,et al. Box 3-independent Signaling Mechanisms Are Involved in Leukemia Inhibitory Factor Receptor α- and gp130-mediated Stimulation of Mitogen-activated Protein Kinase , 1997, The Journal of Biological Chemistry.
[37] M. Hibi,et al. Vav is associated with signal transducing molecules gp130, Grb2 and Erk2, and is tyrosine phosphorylated in response to interleukin‐6 , 1997, FEBS letters.
[38] E. Furth,et al. Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice , 1996, Science.
[39] T. Hirano,et al. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. , 1996, Immunity.
[40] E. Wolf,et al. The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL- 6 and prolongation of the plasma half-life of IL-6 , 1996, The Journal of experimental medicine.
[41] M. Marshall,et al. Interleukin-11 Induces Complex Formation of Grb2, Fyn, and JAK2 in 3T3L1 Cells (*) , 1995, The Journal of Biological Chemistry.
[42] J. Darnell,et al. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors , 1995, Science.
[43] G. Fantuzzi,et al. Defective inflammatory response in interleukin 6-deficient mice , 1994, The Journal of experimental medicine.
[44] M. Waki,et al. Soluble interleukin‐6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism , 1994, European journal of immunology.
[45] P. Heinrich,et al. The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site. , 1994, Journal of immunology.
[46] A. Dunn,et al. Functional and biochemical association of Hck with the LIF/IL‐6 receptor signal transducing subunit gp130 in embryonic stem cells. , 1994, The EMBO journal.
[47] R. Zinkernagel,et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice , 1994, Nature.
[48] G. Ciliberto,et al. Interleukin‐6 deficient mice are protected from bone loss caused by estrogen depletion. , 1994, The EMBO journal.
[49] G. Yancopoulos,et al. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. , 1994, Science.
[50] C. Schindler,et al. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. , 1994, Science.
[51] K. Yasukawa,et al. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. , 1993, Science.
[52] G. Fuller,et al. Ciliary neurotrophic factor regulates fibrinogen gene expression in hepatocytes by binding to the interleukin-6 receptor. , 1993, Biochemical and biophysical research communications.
[53] P. Heinrich,et al. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level , 1993, Molecular and cellular biology.
[54] P. Heinrich,et al. Protein kinase C activity is rate limiting for shedding of the interleukin-6 receptor. , 1992, Biochemical and biophysical research communications.
[55] P. Heinrich,et al. Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins. , 1992, Journal of immunology.
[56] S. Rosenberg,et al. Antitumor activity of recombinant interleukin 6 in mice , 1990, The Journal of experimental medicine.
[57] T. Hirano,et al. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130 , 1989, Cell.
[58] R. Ross,et al. The neutrophilic leukocyte in wound repair a study with antineutrophil serum. , 1972, The Journal of clinical investigation.
[59] B. Jenkins,et al. Acquiring signalling specificity from the cytokine receptor gp130. , 2004, Trends in genetics : TIG.
[60] C. Ohlsson,et al. Interleukin-6-deficient mice develop mature-onset obesity , 2002, Nature Medicine.
[61] N. Hynes,et al. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells. , 2001, Cancer research.
[62] S. Tóth,et al. Soluble interleukin-6 receptor in plasma and in lymphocyte culture supernatants of healthy individuals and patients with systemic lupus erythematosus and rheumatoid arthritis. , 2000, Medical science monitor : international medical journal of experimental and clinical research.
[63] T. Hirano,et al. Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses. , 2000, Immunity.
[64] J. Gauldie,et al. Regulation of IL-6 and the hepatic IL-6 receptor in acute inflammation in vivo. , 1993, Cytokine.
[65] M. B. Grivell,et al. Techniques for pharmacological and toxicological studies with isolated hepatocyte suspensions. , 1992, Life sciences.
[66] R. Ross,et al. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. , 1975, The American journal of pathology.